COVID-19 in a Patient With Severe Eosinophilic Asthma on Benralizumab Therapy: A Case Report and Review of Literature

Patients with coronavirus disease 2019 (COVID-19) can develop eosinopenia. Eosinophils have various functions, including immunoregulation and antiviral activity, in addition to modulation of an inflammatory reaction. Benralizumab is an anti-interleukin-5Rα monoclonal antibody that selectively deplet...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuno, Osamu, Minamoto, Seijiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783696/
https://www.ncbi.nlm.nih.gov/pubmed/35103205
http://dx.doi.org/10.7759/cureus.20644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783696/
https://www.ncbi.nlm.nih.gov/pubmed/35103205
http://dx.doi.org/10.7759/cureus.20644

Ejemplares similares